| ADR Ontology |
| ADR Term |
Chronic inflammatory demyelinating polyradiculoneuropathy |
| ADR ID |
BADD_A05515 |
| ADR Hierarchy |
|
| Description |
A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337) [MeSH] |
| MedDRA Code |
10057645 |
| MeSH ID |
D020277; D020277; D020277
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Chronic inflammatory demyelinating polyradiculoneuropathy | CIDP | Chronic inflammatory demyelinating polyneuropathy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Polyneuropathy, Inflammatory Demyelinating, Chronic | Inflammatory Polyradiculopathy, Chronic | Chronic Inflammatory Polyradiculopathies | Chronic Inflammatory Polyradiculopathy | Inflammatory Polyradiculopathies, Chronic | Polyradiculopathies, Chronic Inflammatory | Polyradiculopathy, Chronic Inflammatory | Polyradiculoneuropathy, Chronic Inflammatory | Chronic Inflammatory Polyradiculoneuropathy | Chronic Inflammatory Polyradiculoneuropathies | Polyradiculoneuropathies, Chronic Inflammatory | Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
